S H Kelkar and Company Limited
S H Kelkar and Company Limited (SHK) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
keva.co.in(opens the company website in a new tab)Key metrics
Price as of 2026-09-04
Stock price
₹150.87
Market cap
2,088 Cr
Stock P/E
18.6
P/B
1.53
Dividend yield
1.3%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 455 Cr | 496 Cr | 533 Cr | 470 Cr | 543 Cr | 543 Cr | 567 Cr | 581 Cr | 554 Cr | 584 Cr | 650 Cr | 662 Cr |
| Operating expenses (approx.) | 384 Cr | 419 Cr | 445 Cr | 392 Cr | 462 Cr | 479 Cr | 494 Cr | 508 Cr | 501 Cr | 528 Cr | 590 Cr | 574 Cr |
| EBITDA | 72 Cr | 77 Cr | 88 Cr | 78 Cr | 81 Cr | 65 Cr | 73 Cr | 73 Cr | 53 Cr | 56 Cr | 60 Cr | 89 Cr |
| OPM % | 15.7% | 15.5% | 16.5% | 16.6% | 14.9% | 11.9% | 12.9% | 12.6% | 9.5% | 9.6% | 9.2% | 13.4% |
| Other income | 2 Cr | 2 Cr | 2 Cr | 0.65 Cr | 21 Cr | 0.89 Cr | 2 Cr | 0.81 Cr | 0.32 Cr | 1 Cr | 7 Cr | 0.81 Cr |
| Interest | 10 Cr | 11 Cr | 10 Cr | 10 Cr | 13 Cr | 14 Cr | 13 Cr | 13 Cr | 14 Cr | 14 Cr | 15 Cr | 15 Cr |
| Depreciation | 22 Cr | 23 Cr | 23 Cr | 22 Cr | 24 Cr | 23 Cr | 25 Cr | 26 Cr | 27 Cr | 27 Cr | 39 Cr | 35 Cr |
| Profit before tax | 41 Cr | 46 Cr | 57 Cr | -74 Cr | 64 Cr | 27 Cr | 97 Cr | 37 Cr | 12 Cr | 49 Cr | 15 Cr | 69 Cr |
| Tax % | 26.7% | 29.4% | 40.9% | -16.7% | 37.6% | 36.0% | -5.7% | 30.2% | 24.6% | 33.5% | 87.7% | 34.3% |
| Net profit | 30 Cr | 32 Cr | 33 Cr | -87 Cr | 40 Cr | 18 Cr | 103 Cr | 26 Cr | 9 Cr | 33 Cr | 2 Cr | 45 Cr |
| EPS (₹) | ₹2.16 | ₹2.37 | ₹2.46 | ₹-6.25 | ₹2.87 | ₹1.27 | ₹7.41 | ₹1.85 | ₹0.66 | ₹2.36 | ₹0.13 | ₹3.28 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,044 Cr | 1,114 Cr | 1,322 Cr | 1,564 Cr | 1,687 Cr | 1,930 Cr | 2,123 Cr | 2,368 Cr | Sign in for TTM |
| Operating expenses (approx.) | 912 Cr | 956 Cr | 1,086 Cr | 1,350 Cr | 1,469 Cr | 1,623 Cr | 1,826 Cr | 2,126 Cr | Sign in for TTM |
| EBITDA | 132 Cr | 158 Cr | 236 Cr | 215 Cr | 217 Cr | 307 Cr | 297 Cr | 242 Cr | Sign in for TTM |
| OPM % | 12.7% | 14.2% | 17.8% | 13.7% | 12.9% | 15.9% | 14.0% | 10.2% | Sign in for TTM |
| Other income | 28 Cr | 8 Cr | 23 Cr | 18 Cr | 12 Cr | 6 Cr | 24 Cr | 10 Cr | Sign in for TTM |
| Interest | 14 Cr | 25 Cr | 17 Cr | 16 Cr | 24 Cr | 41 Cr | 49 Cr | 56 Cr | Sign in for TTM |
| Depreciation | 31 Cr | 52 Cr | 62 Cr | 72 Cr | 80 Cr | 89 Cr | 95 Cr | 119 Cr | Sign in for TTM |
| Profit before tax | 115 Cr | 54 Cr | 194 Cr | 132 Cr | 104 Cr | 182 Cr | 114 Cr | 112 Cr | Sign in for TTM |
| Tax % | 23.4% | 34.2% | 25.6% | -13.0% | 39.7% | 32.2% | 35.8% | 38.5% | Sign in for TTM |
| Net profit | 88 Cr | 36 Cr | 144 Cr | 149 Cr | 63 Cr | 124 Cr | 73 Cr | 69 Cr | Sign in for TTM |
| EPS (₹) | ₹6.20 | ₹2.56 | ₹10.48 | ₹10.81 | ₹4.53 | ₹8.93 | ₹5.31 | ₹5.00 | Sign in for TTM |
| Dividend payout % | — | — | — | 7.1% | 29.8% | 23.8% | 14.2% | 40.0% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 145 Cr | 141 Cr | 141 Cr | 138 Cr | 138 Cr | 138 Cr | 138 Cr | 138 Cr |
| Reserves | 719 Cr | 683 Cr | 810 Cr | 875 Cr | 926 Cr | 1,074 Cr | 1,134 Cr | 1,223 Cr |
| Borrowings | 334 Cr | — | — | — | 620 Cr | 617 Cr | 745 Cr | 851 Cr |
| Other liabilities | 237 Cr | 666 Cr | 946 Cr | 1,284 Cr | 499 Cr | 571 Cr | 668 Cr | 700 Cr |
| Total liabilities | 1,445 Cr | 1,490 Cr | 1,898 Cr | 2,297 Cr | 2,222 Cr | 2,402 Cr | 2,685 Cr | 2,913 Cr |
| Fixed assets (net) | 369 Cr | — | — | — | 387 Cr | 419 Cr | 460 Cr | 464 Cr |
| CWIP | 15 Cr | — | — | — | 22 Cr | 7 Cr | 39 Cr | 90 Cr |
| Investments | 111 Cr | — | — | — | 24 Cr | 10 Cr | 12 Cr | 12 Cr |
| Loans & advances | 6 Cr | — | — | — | 6 Cr | 3 Cr | 8 Cr | 10 Cr |
| Inventories | 374 Cr | — | — | — | 603 Cr | 657 Cr | 718 Cr | 665 Cr |
| Trade receivables | 284 Cr | — | — | — | 438 Cr | 490 Cr | 506 Cr | 635 Cr |
| Cash & bank | 37 Cr | — | — | — | 64 Cr | 100 Cr | 86 Cr | 64 Cr |
| Other assets | 247 Cr | 1,490 Cr | 1,898 Cr | 2,297 Cr | 679 Cr | 717 Cr | 856 Cr | 972 Cr |
| Total assets | 1,445 Cr | 1,490 Cr | 1,898 Cr | 2,297 Cr | 2,222 Cr | 2,402 Cr | 2,685 Cr | 2,913 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 50 Cr | 189 Cr | 107 Cr | 16 Cr | 263 Cr |
| Cash from investing | — | — | — | -160 Cr | -103 Cr | -82 Cr | -72 Cr | -205 Cr |
| Cash from financing | — | — | — | 13 Cr | -175 Cr | 8 Cr | 99 Cr | -158 Cr |
| Net cash flow | — | — | — | -97 Cr | -88 Cr | 34 Cr | 41 Cr | -104 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 23 Cr | 121 Cr | 47 Cr | -80 Cr | 57 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 10.7% | 9.6% | 22.1% | 14.6% | 7.4% | 12.2% | 8.1% | 7.6% |
| ROE % | 0.0% | 0.0% | 0.0% | 14.7% | 5.5% | 10.1% | 5.8% | 5.1% |
| Debtor days | 99 | — | — | — | 95 | 93 | 87 | 98 |
| Inventory days | 223 | — | — | — | 221 | 230 | 200 | 180 |
| Days payable | 80 | — | — | — | 134 | 124 | 111 | 89 |
| Cash conversion cycle | 242 | — | — | — | 182 | 198 | 175 | 188 |
| Debt / equity | 0.39 | 0.00 | 0.00 | 0.00 | 0.58 | 0.51 | 0.59 | 0.62 |
| Current ratio | 1.60 | — | — | — | 1.70 | 1.52 | 1.39 | 1.27 |
| Net debt / EBITDA | 2.25 | 0.00 | 0.00 | 0.00 | 2.56 | 1.68 | 2.22 | 3.25 |
Compare with peers
Loading peers…